Glycopyrronium cloth improves axillary hyperhidrosis across a broad spectrum of patients: Post hoc analyses of the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials in patient subpopulations

doi:10.1016/j.jaad.2019.06.797

Glycopyrronium cloth improves axillary hyperhidrosis across a broad spectrum of patients: Post hoc analyses of the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials in patient subpopulations

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2019.06.797 ◽

2019 ◽

Vol 81 (4) ◽

pp. AB217

Keyword(s):

Randomized Controlled Trials ◽

Broad Spectrum ◽

Controlled Trials ◽

Axillary Hyperhidrosis ◽

Phase 3 ◽

Randomized Controlled ◽

Spectrum Of Patients ◽

Post Hoc

Download Full-text

Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.07.002 ◽

2019 ◽

Vol 80 (1) ◽

pp. 128-138.e2 ◽

Cited By ~ 20

Author(s):

Dee Anna Glaser ◽

Adelaide A. Hebert ◽

Alexander Nast ◽

William P. Werschler ◽

Lawrence Green ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Controlled Trials ◽

Axillary Hyperhidrosis ◽

Phase 3 ◽

Randomized Controlled

Download Full-text

Topical glycopyrronium tosylate (DRM04) for the treatment of primary axillary hyperhidrosis: Pooled results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.1178 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB298

Keyword(s):

Randomized Controlled Trials ◽

Controlled Trials ◽

Axillary Hyperhidrosis ◽

Phase 3 ◽

Randomized Controlled

Download Full-text

DRM04 for the treatment of primary axillary hyperhidrosis: Primary results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2017.04.419 ◽

2017 ◽

Vol 76 (6) ◽

pp. AB105

Keyword(s):

Randomized Controlled Trials ◽

Controlled Trials ◽

Axillary Hyperhidrosis ◽

Phase 3 ◽

Randomized Controlled

Download Full-text

Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials

Pediatric Dermatology ◽

10.1111/pde.13723 ◽

2018 ◽

Vol 36 (1) ◽

pp. 89-99 ◽

Cited By ~ 10

Author(s):

Adelaide A. Hebert ◽

Dee Anna Glaser ◽

Lawrence Green ◽

William P. Werschler ◽

Douglass W. Forsha ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Controlled Trials ◽

Efficacy And Safety ◽

Axillary Hyperhidrosis ◽

Two Phase ◽

Post Hoc Analysis ◽

Randomized Controlled ◽

Post Hoc

Download Full-text

Glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Previous treatment analyses from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.607 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB147

Keyword(s):

Randomized Controlled Trials ◽

Previous Treatment ◽

Controlled Trials ◽

Axillary Hyperhidrosis ◽

Phase 3 ◽

Randomized Controlled

Download Full-text

Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials

Pediatric Dermatology ◽

10.1111/pde.13877 ◽

2019 ◽

Vol 36 (3) ◽

pp. 424-424

Keyword(s):

Randomized Controlled Trials ◽

Controlled Trials ◽

Efficacy And Safety ◽

Axillary Hyperhidrosis ◽

Two Phase ◽

Post Hoc Analysis ◽

Randomized Controlled ◽

Post Hoc

Download Full-text

Efficacy, Safety, and Tolerability of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination in the Treatment of Severe Plaque Psoriasis: Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.29 ◽

2019 ◽

Vol 3 ◽

pp. S29

Author(s):

Mark G Lebwohl ◽

Jeffrey L Sugarman ◽

Linda Stein Gold ◽

Tina Lin ◽

Gina Martin

Keyword(s):

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Fixed Combination ◽

Controlled Trials ◽

Phase 3 ◽

Two Phase ◽

Severe Plaque Psoriasis ◽

Post Hoc Analysis ◽

Randomized Controlled ◽

Post Hoc

Abstract not available.

Download Full-text

Efficacy, Safety, and Tolerability of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis in a Hispanic Population: Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.28 ◽

2019 ◽

Vol 3 ◽

pp. S28

Author(s):

Andrew F Alexis ◽

Paul S Yamauchi ◽

Tina Lin ◽

Gina Martin

Keyword(s):

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Fixed Combination ◽

Controlled Trials ◽

Hispanic Population ◽

Phase 3 ◽

Two Phase ◽

Post Hoc Analysis ◽

Randomized Controlled ◽

Post Hoc

Abstract not available.

Download Full-text

Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials

American Journal of Clinical Dermatology ◽

10.1007/s40257-018-0395-0 ◽

2018 ◽

Vol 20 (1) ◽

pp. 135-145 ◽

Cited By ~ 9

Author(s):

David M. Pariser ◽

Adelaide A. Hebert ◽

Janice Drew ◽

John Quiring ◽

Ramanan Gopalan ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Patient Reported Outcomes ◽

Phase Iii ◽

Controlled Trials ◽

Axillary Hyperhidrosis ◽

Randomized Controlled ◽

Patient Reported

Download Full-text

Rationale and design of two, phase 3, randomized controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory and unexplained chronic cough

World Allergy Organization Journal ◽

10.1016/j.waojou.2020.100203 ◽

2020 ◽

Vol 13 (8) ◽

pp. 100203

Author(s):

David Muccino ◽

George Philip ◽

A.H. Morice ◽

S.S. Birring ◽

L. Mcgarvey ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Receptor Antagonist ◽

Chronic Cough ◽

Controlled Trials ◽

P2x3 Receptor ◽

Phase 3 ◽

Two Phase ◽

Randomized Controlled

Download Full-text